Motif ID: Pou6f2_Pou4f2
Z-value: 0.738
Transcription factors associated with Pou6f2_Pou4f2:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Pou4f2 | ENSMUSG00000031688.3 | Pou4f2 |
Pou6f2 | ENSMUSG00000009734.11 | Pou6f2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Pou4f2 | mm10_v2_chr8_-_78436640_78436649 | 0.40 | 5.4e-04 | Click! |
Pou6f2 | mm10_v2_chr13_-_18382041_18382041 | -0.07 | 5.5e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
2.1 | 6.2 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
2.0 | 6.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
1.7 | 5.1 | GO:0021759 | globus pallidus development(GO:0021759) |
1.6 | 4.7 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
1.5 | 19.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.3 | 5.0 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.2 | 3.6 | GO:0021893 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
1.0 | 3.0 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
1.0 | 6.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.9 | 7.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.8 | 5.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 3.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 2.0 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.4 | 6.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.6 | GO:0060032 | notochord regression(GO:0060032) |
0.3 | 1.3 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 1.9 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.3 | 2.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 4.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 4.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 2.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 6.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 1.3 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 1.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 2.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 2.9 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.9 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 1.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 1.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 4.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.2 | GO:0045014 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 1.9 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 2.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.0 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.8 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 19.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 6.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 1.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 3.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 2.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.3 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 5.0 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 5.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 4.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 6.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 3.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 1.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.0 | 3.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.0 | 5.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.8 | 5.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 5.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 1.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 6.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 19.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 2.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 5.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.4 | 2.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 4.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 11.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 3.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 1.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.3 | 6.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.3 | 1.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 6.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 3.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.4 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 2.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 3.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 24.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |